Metacrine to Present New Data from MET409 Program in NASH at AASLD’s The Liver Meeting Digital Experience™
SAN DIEGO, Oct. 01, 2020 (GLOBE NEWSWIRE) — Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and […]